|
|
||||||||
The Annals of Thoracic Surgery, Vol 25, 510-515, Copyright © 1978 by The Society of Thoracic Surgeons
RE Johnson, HD Brereton and CH Kent
Seventy-one consecutive patients with small cell carcinoma of the lung were
treated with an integrated approach between November, 1974, and May, 1977.
The regimen included radiotherapy to the primary site, relatively brief (6
to 12 weeks) although intensive chemotherapy, and prophylactic cranial
irradiation. Complete responses were achieved in 75% and 40% of patients
with limited and extensive disease, respectively. Modest prolongation of
survival (median, 10 months) was realized by patients with extensive
disease, but prolonged relapse-free survival was not observed. In contrast,
one-half of the patients with limited disease who achieved a complete
response have remained clinically free of disease without further treatment
for a mean of 18 months (range, 6 to 33 months). Since all relapses to date
have been noted within the first year following cessation of treatment,
this experience suggests there may be a potential for cure in those
survivors who are now relapse free for intervals exceeding two years.
ARTICLES
"Total" therapy for small cell carcinoma of the lung
This article has been cited by other articles:
![]() |
D. H. Johnson "The Guard Dies, It Does Not Surrender!" Progress in the Management of Small-Cell Lung Cancer? J. Clin. Oncol., December 15, 2002; 20(24): 4618 - 4620. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |